The global market for Implantable Drug Delivery Systems was valued at US$ 518 million in the year 2024 and is projected to reach a revised size of US$ 730 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Implantable Drug Delivery Systems Market

Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. This system is more steady, effective, safe and reliable than other drug delivery system. For intravenous drug delivery system, drugs actions were short, and frequent injections were required. For topical drug delivery system, absorption drug may be limited due physiochemical characteristic of drugs. Implantable drug delivery system does not have limitation associated with intravenous and topical drug delivery system beside it is controlled drug delivery system.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Implantable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Drug Delivery Systems.

The Implantable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Implantable Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Implantable Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Implantable Drug Delivery Systems Market
Accounted market size in year	US$ 518 million
Forecasted market size in 2031	US$ 730 million
CAGR	5.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Biodegradable Non-Biodegradable
Segment by Application	Diabetic Retinopathy Cardiovascular Diseases Colorectal Cancer Osteoporosis Ocular Diseases Brain Tumors Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation, Medtronic, Varian Medical System, Arrow International, Neurotech Pharmaceuticals, Replenish Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Implantable Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Implantable Drug Delivery Systems Market growing?

Ans: The Implantable Drug Delivery Systems Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Implantable Drug Delivery Systems Market size in 2031?

Ans: The Implantable Drug Delivery Systems Market size in 2031 will be US$ 730 million.

Who are the main players in the Implantable Drug Delivery Systems Market report?

Ans: The main players in the Implantable Drug Delivery Systems Market are Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation, Medtronic, Varian Medical System, Arrow International, Neurotech Pharmaceuticals, Replenish Inc.

What are the Application segmentation covered in the Implantable Drug Delivery Systems Market report?

Ans: The Applications covered in the Implantable Drug Delivery Systems Market report are Diabetic Retinopathy, Cardiovascular Diseases, Colorectal Cancer, Osteoporosis, Ocular Diseases, Brain Tumors, Other

What are the Type segmentation covered in the Implantable Drug Delivery Systems Market report?

Ans: The Types covered in the Implantable Drug Delivery Systems Market report are Biodegradable, Non-Biodegradable

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Implantable Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biodegradable

1.2.3 Non-Biodegradable

1.3 Market by Application

1.3.1 Global Implantable Drug Delivery Systems Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diabetic Retinopathy

1.3.3 Cardiovascular Diseases

1.3.4 Colorectal Cancer

1.3.5 Osteoporosis

1.3.6 Ocular Diseases

1.3.7 Brain Tumors

1.3.8 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Implantable Drug Delivery Systems Market Perspective (2020-2031)

2.2 Global Implantable Drug Delivery Systems Growth Trends by Region

2.2.1 Global Implantable Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Implantable Drug Delivery Systems Historic Market Size by Region (2020-2025)

2.2.3 Implantable Drug Delivery Systems Forecasted Market Size by Region (2026-2031)

2.3 Implantable Drug Delivery Systems Market Dynamics

2.3.1 Implantable Drug Delivery Systems Industry Trends

2.3.2 Implantable Drug Delivery Systems Market Drivers

2.3.3 Implantable Drug Delivery Systems Market Challenges

2.3.4 Implantable Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Implantable Drug Delivery Systems Players by Revenue

3.1.1 Global Top Implantable Drug Delivery Systems Players by Revenue (2020-2025)

3.1.2 Global Implantable Drug Delivery Systems Revenue Market Share by Players (2020-2025)

3.2 Global Implantable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Implantable Drug Delivery Systems Revenue

3.4 Global Implantable Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Implantable Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Implantable Drug Delivery Systems Revenue in 2024

3.5 Global Key Players of Implantable Drug Delivery Systems Head office and Area Served

3.6 Global Key Players of Implantable Drug Delivery Systems, Product and Application

3.7 Global Key Players of Implantable Drug Delivery Systems, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Implantable Drug Delivery Systems Breakdown Data by Type

4.1 Global Implantable Drug Delivery Systems Historic Market Size by Type (2020-2025)

4.2 Global Implantable Drug Delivery Systems Forecasted Market Size by Type (2026-2031)

5 Implantable Drug Delivery Systems Breakdown Data by Application

5.1 Global Implantable Drug Delivery Systems Historic Market Size by Application (2020-2025)

5.2 Global Implantable Drug Delivery Systems Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Implantable Drug Delivery Systems Market Size (2020-2031)

6.2 North America Implantable Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Implantable Drug Delivery Systems Market Size by Country (2020-2025)

6.4 North America Implantable Drug Delivery Systems Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Implantable Drug Delivery Systems Market Size (2020-2031)

7.2 Europe Implantable Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Implantable Drug Delivery Systems Market Size by Country (2020-2025)

7.4 Europe Implantable Drug Delivery Systems Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Implantable Drug Delivery Systems Market Size (2020-2031)

8.2 Asia-Pacific Implantable Drug Delivery Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2020-2025)

8.4 Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Implantable Drug Delivery Systems Market Size (2020-2031)

9.2 Latin America Implantable Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Implantable Drug Delivery Systems Market Size by Country (2020-2025)

9.4 Latin America Implantable Drug Delivery Systems Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Implantable Drug Delivery Systems Market Size (2020-2031)

10.2 Middle East & Africa Implantable Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2020-2025)

10.4 Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Boston Scientific Corporation

11.1.1 Boston Scientific Corporation Company Details

11.1.2 Boston Scientific Corporation Business Overview

11.1.3 Boston Scientific Corporation Implantable Drug Delivery Systems Introduction

11.1.4 Boston Scientific Corporation Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.1.5 Boston Scientific Corporation Recent Development

11.2 Bayer Healthcare

11.2.1 Bayer Healthcare Company Details

11.2.2 Bayer Healthcare Business Overview

11.2.3 Bayer Healthcare Implantable Drug Delivery Systems Introduction

11.2.4 Bayer Healthcare Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.2.5 Bayer Healthcare Recent Development

11.3 Medtronic Inc.

11.3.1 Medtronic Inc. Company Details

11.3.2 Medtronic Inc. Business Overview

11.3.3 Medtronic Inc. Implantable Drug Delivery Systems Introduction

11.3.4 Medtronic Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.3.5 Medtronic Inc. Recent Development

11.4 Allergan Inc.

11.4.1 Allergan Inc. Company Details

11.4.2 Allergan Inc. Business Overview

11.4.3 Allergan Inc. Implantable Drug Delivery Systems Introduction

11.4.4 Allergan Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.4.5 Allergan Inc. Recent Development

11.5 Abbott laboratories

11.5.1 Abbott laboratories Company Details

11.5.2 Abbott laboratories Business Overview

11.5.3 Abbott laboratories Implantable Drug Delivery Systems Introduction

11.5.4 Abbott laboratories Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.5.5 Abbott laboratories Recent Development

11.6 Bausch and Lomb Inc.

11.6.1 Bausch and Lomb Inc. Company Details

11.6.2 Bausch and Lomb Inc. Business Overview

11.6.3 Bausch and Lomb Inc. Implantable Drug Delivery Systems Introduction

11.6.4 Bausch and Lomb Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.6.5 Bausch and Lomb Inc. Recent Development

11.7 Genetech Inc.

11.7.1 Genetech Inc. Company Details

11.7.2 Genetech Inc. Business Overview

11.7.3 Genetech Inc. Implantable Drug Delivery Systems Introduction

11.7.4 Genetech Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.7.5 Genetech Inc. Recent Development

11.8 PSivda Corporation

11.8.1 PSivda Corporation Company Details

11.8.2 PSivda Corporation Business Overview

11.8.3 PSivda Corporation Implantable Drug Delivery Systems Introduction

11.8.4 PSivda Corporation Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.8.5 PSivda Corporation Recent Development

11.9 Medtronic

11.9.1 Medtronic Company Details

11.9.2 Medtronic Business Overview

11.9.3 Medtronic Implantable Drug Delivery Systems Introduction

11.9.4 Medtronic Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.9.5 Medtronic Recent Development

11.10 Varian Medical System

11.10.1 Varian Medical System Company Details

11.10.2 Varian Medical System Business Overview

11.10.3 Varian Medical System Implantable Drug Delivery Systems Introduction

11.10.4 Varian Medical System Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.10.5 Varian Medical System Recent Development

11.11 Arrow International

11.11.1 Arrow International Company Details

11.11.2 Arrow International Business Overview

11.11.3 Arrow International Implantable Drug Delivery Systems Introduction

11.11.4 Arrow International Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.11.5 Arrow International Recent Development

11.12 Neurotech Pharmaceuticals

11.12.1 Neurotech Pharmaceuticals Company Details

11.12.2 Neurotech Pharmaceuticals Business Overview

11.12.3 Neurotech Pharmaceuticals Implantable Drug Delivery Systems Introduction

11.12.4 Neurotech Pharmaceuticals Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.12.5 Neurotech Pharmaceuticals Recent Development

11.13 Replenish Inc.

11.13.1 Replenish Inc. Company Details

11.13.2 Replenish Inc. Business Overview

11.13.3 Replenish Inc. Implantable Drug Delivery Systems Introduction

11.13.4 Replenish Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025)

11.13.5 Replenish Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boston Scientific Corporation

Varian Medical System

Arrow International

Neurotech Pharmaceuticals

Replenish Inc.

Medtronic Inc

List of Tables

Table 1. Global Implantable Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biodegradable

Table 3. Key Players of Non-Biodegradable

Table 4. Global Implantable Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Implantable Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Implantable Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Implantable Drug Delivery Systems Market Share by Region (2020-2025)

Table 8. Global Implantable Drug Delivery Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Implantable Drug Delivery Systems Market Share by Region (2026-2031)

Table 10. Implantable Drug Delivery Systems Market Trends

Table 11. Implantable Drug Delivery Systems Market Drivers

Table 12. Implantable Drug Delivery Systems Market Challenges

Table 13. Implantable Drug Delivery Systems Market Restraints

Table 14. Global Implantable Drug Delivery Systems Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Implantable Drug Delivery Systems Market Share by Players (2020-2025)

Table 16. Global Top Implantable Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug Delivery Systems as of 2024)

Table 17. Ranking of Global Top Implantable Drug Delivery Systems Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Implantable Drug Delivery Systems Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Implantable Drug Delivery Systems, Headquarters and Area Served

Table 20. Global Key Players of Implantable Drug Delivery Systems, Product and Application

Table 21. Global Key Players of Implantable Drug Delivery Systems, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Implantable Drug Delivery Systems Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Implantable Drug Delivery Systems Revenue Market Share by Type (2020-2025)

Table 25. Global Implantable Drug Delivery Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Implantable Drug Delivery Systems Revenue Market Share by Type (2026-2031)

Table 27. Global Implantable Drug Delivery Systems Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Implantable Drug Delivery Systems Revenue Market Share by Application (2020-2025)

Table 29. Global Implantable Drug Delivery Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Implantable Drug Delivery Systems Revenue Market Share by Application (2026-2031)

Table 31. North America Implantable Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Implantable Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Implantable Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Implantable Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Implantable Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Implantable Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Implantable Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Implantable Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Implantable Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Implantable Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Implantable Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 46. Boston Scientific Corporation Company Details

Table 47. Boston Scientific Corporation Business Overview

Table 48. Boston Scientific Corporation Implantable Drug Delivery Systems Product

Table 49. Boston Scientific Corporation Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 50. Boston Scientific Corporation Recent Development

Table 51. Bayer Healthcare Company Details

Table 52. Bayer Healthcare Business Overview

Table 53. Bayer Healthcare Implantable Drug Delivery Systems Product

Table 54. Bayer Healthcare Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 55. Bayer Healthcare Recent Development

Table 56. Medtronic Inc. Company Details

Table 57. Medtronic Inc. Business Overview

Table 58. Medtronic Inc. Implantable Drug Delivery Systems Product

Table 59. Medtronic Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 60. Medtronic Inc. Recent Development

Table 61. Allergan Inc. Company Details

Table 62. Allergan Inc. Business Overview

Table 63. Allergan Inc. Implantable Drug Delivery Systems Product

Table 64. Allergan Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 65. Allergan Inc. Recent Development

Table 66. Abbott laboratories Company Details

Table 67. Abbott laboratories Business Overview

Table 68. Abbott laboratories Implantable Drug Delivery Systems Product

Table 69. Abbott laboratories Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 70. Abbott laboratories Recent Development

Table 71. Bausch and Lomb Inc. Company Details

Table 72. Bausch and Lomb Inc. Business Overview

Table 73. Bausch and Lomb Inc. Implantable Drug Delivery Systems Product

Table 74. Bausch and Lomb Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 75. Bausch and Lomb Inc. Recent Development

Table 76. Genetech Inc. Company Details

Table 77. Genetech Inc. Business Overview

Table 78. Genetech Inc. Implantable Drug Delivery Systems Product

Table 79. Genetech Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 80. Genetech Inc. Recent Development

Table 81. PSivda Corporation Company Details

Table 82. PSivda Corporation Business Overview

Table 83. PSivda Corporation Implantable Drug Delivery Systems Product

Table 84. PSivda Corporation Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 85. PSivda Corporation Recent Development

Table 86. Medtronic Company Details

Table 87. Medtronic Business Overview

Table 88. Medtronic Implantable Drug Delivery Systems Product

Table 89. Medtronic Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 90. Medtronic Recent Development

Table 91. Varian Medical System Company Details

Table 92. Varian Medical System Business Overview

Table 93. Varian Medical System Implantable Drug Delivery Systems Product

Table 94. Varian Medical System Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 95. Varian Medical System Recent Development

Table 96. Arrow International Company Details

Table 97. Arrow International Business Overview

Table 98. Arrow International Implantable Drug Delivery Systems Product

Table 99. Arrow International Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 100. Arrow International Recent Development

Table 101. Neurotech Pharmaceuticals Company Details

Table 102. Neurotech Pharmaceuticals Business Overview

Table 103. Neurotech Pharmaceuticals Implantable Drug Delivery Systems Product

Table 104. Neurotech Pharmaceuticals Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 105. Neurotech Pharmaceuticals Recent Development

Table 106. Replenish Inc. Company Details

Table 107. Replenish Inc. Business Overview

Table 108. Replenish Inc. Implantable Drug Delivery Systems Product

Table 109. Replenish Inc. Revenue in Implantable Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 110. Replenish Inc. Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Implantable Drug Delivery Systems Picture

Figure 2. Global Implantable Drug Delivery Systems Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Implantable Drug Delivery Systems Market Share by Type: 2024 VS 2031

Figure 4. Biodegradable Features

Figure 5. Non-Biodegradable Features

Figure 6. Global Implantable Drug Delivery Systems Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Implantable Drug Delivery Systems Market Share by Application: 2024 VS 2031

Figure 8. Diabetic Retinopathy Case Studies

Figure 9. Cardiovascular Diseases Case Studies

Figure 10. Colorectal Cancer Case Studies

Figure 11. Osteoporosis Case Studies

Figure 12. Ocular Diseases Case Studies

Figure 13. Brain Tumors Case Studies

Figure 14. Other Case Studies

Figure 15. Implantable Drug Delivery Systems Report Years Considered

Figure 16. Global Implantable Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Implantable Drug Delivery Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Implantable Drug Delivery Systems Market Share by Region: 2024 VS 2031

Figure 19. Global Implantable Drug Delivery Systems Market Share by Players in 2024

Figure 20. Global Top Implantable Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug Delivery Systems as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Implantable Drug Delivery Systems Revenue in 2024

Figure 22. North America Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Implantable Drug Delivery Systems Market Share by Country (2020-2031)

Figure 24. United States Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Implantable Drug Delivery Systems Market Share by Country (2020-2031)

Figure 28. Germany Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Implantable Drug Delivery Systems Market Share by Region (2020-2031)

Figure 36. China Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Implantable Drug Delivery Systems Market Share by Country (2020-2031)

Figure 44. Mexico Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Implantable Drug Delivery Systems Market Share by Country (2020-2031)

Figure 48. Turkey Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Implantable Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Boston Scientific Corporation Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 52. Bayer Healthcare Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 53. Medtronic Inc. Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 54. Allergan Inc. Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 55. Abbott laboratories Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 56. Bausch and Lomb Inc. Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 57. Genetech Inc. Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 58. PSivda Corporation Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 59. Medtronic Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 60. Varian Medical System Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 61. Arrow International Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 62. Neurotech Pharmaceuticals Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 63. Replenish Inc. Revenue Growth Rate in Implantable Drug Delivery Systems Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions